Open Tender for Anastrazole 1 mg Tab,Tab Folic Acid 5 mg,Deflazacort 6 mg Tab,Tab Iguratimod 25 mg,Ezetimibe 10 mg in KANNUR, KERALA
Progress
Quantity
1585
Category
Anastrazole 1 mg Tab
Bid Type
Two Packet Bid
Categories
7
Dg Armed Forces Medical Service announces a tender for Anastrazole 1 mg Tab, Tab Folic Acid 5 mg, Deflazacort 6 mg Tab, Tab Iguratimod 25 mg, Ezetimibe 10 mg Tab, Rosuvastatin 40 mg Tab, Methotrexate 10 mg Tab, Inj Degludec or Insulin Aspart of Recombinant DNA Origin of 70 percent Insulin Degludec and 30 percent Insulin Aspart 100 IU or Ml of 3 ml, Inj Insulin Aspart 100 IU or ml Inj of Monocomponent r DNA Originof 300 IU or 3ml Catridges of Novorapid Penfill, Inj Insulin Aspart 100 IU or Ml Monocomponent DNA Origin of 300 IU or 3ML Pen, Recombinant Somatropin for Injection 36 IU of 12 mg or ml, Tab Mesalamine 1 point 2 gm, Mesalamine Suppository 500 mg, Tab Glimepride 2 mg, Tab Dapagliflozin 10 mg, Tab Vildagliptin 50 mg, Cilnidipine 10 mg Tab, Telmisartan 40 mg Tab, Silodosin 8 mg Tab, Inj Zolendronic Acid 4 mg in KANNUR, KERALA. Quantity: 1585. Submission Deadline: 25-02-2025 11: 00: 00. Last date to apply is approaching fast!
Additional Tender Data
Commercial Details
Tender Category
Goods
Bid To RA
No
Bid To RA Enabled
No
Item Category
Anastrazole 1 mg Tab , Tab Folic Acid 5 mg , Deflazacort 6 mg Tab , Tab Iguratimod 25 mg , Ezetimibe 10 mg Tab , Rosuvastatin 40 mg Tab , Methotrexate 10 mg Tab , Inj Degludec or Insulin Aspart of Recombinant DNA Origin of 70 percent Insulin Degludec and 30 percent Insulin Aspart 100 IU or Ml of 3 ml , Inj Insulin Aspart 100 IU or ml Inj of Monocomponent r DNA Originof 300 IU or 3ml Catridges of Novorapid Penfill , Inj Insulin Aspart 100 IU or Ml Monocomponent DNA Origin of 300 IU or 3ML Pen , Recombinant Somatropin for Injection 36 IU of 12 mg or ml , Tab Mesalamine 1 point 2 gm , Mesalamine Suppository 500 mg , Tab Glimepride 2 mg , Tab Dapagliflozin 10 mg , Tab Vildagliptin 50 mg , Cilnidipine 10 mg Tab , Telmisartan 40 mg Tab , Silodosin 8 mg Tab , Inj Zolendronic Acid 4 mg
Authority Records
BID & GeM Expert Consultancy
End-to-end support — bid preparation, GeM registration, document filing & compliance by industry experts.
Free consultation · 24h response
Documents 5
GeM-Bidding-7423380.pdf
Main Document
BOQ Document
BOQ
BOQ Document
BOQ
Other Documents
OTHER
GEM General Terms and Conditions Document
GEM_GENERAL_TERMS_AND_CONDITIONS
Bill of Quantities (BOQ)
20 Items Sign in to view GEM price trends Sign in for GEM prices
Anastrazole 1 mg Tab
Patient Care
Tab Folic Acid 5 mg
Patient Care
Deflazacort 6 mg Tab
Patient Care
Tab Iguratimod 25 mg
Patient Care
Ezetimibe 10 mg Tab
Patient Care
Rosuvastatin 40 mg Tab
Patient Care
Methotrexate 10 mg Tab
Patient Care
Inj Degludec or Insulin Aspart of Recombinant DNA Origin of 70 percent Insulin Degludec and 30 percent Insulin Aspart 100 IU or Ml of 3 ml
Patient Care
Inj Insulin Aspart 100 IU or ml Inj of Monocomponent r DNA Originof 300 IU or 3ml Catridges of Novorapid Penfill
Patient Care
Inj Insulin Aspart 100 IU or Ml Monocomponent DNA Origin of 300 IU or 3ML Pen
Patient Care
Recombinant Somatropin for Injection 36 IU of 12 mg or ml
Patient Care
Tab Mesalamine 1 point 2 gm
Patient Care
Mesalamine Suppository 500 mg
Patient Care
Tab Glimepride 2 mg
Patient Care
Tab Dapagliflozin 10 mg
Patient Care
Tab Vildagliptin 50 mg
Patient Care
Cilnidipine 10 mg Tab
Patient Care
Telmisartan 40 mg Tab
Patient Care
Silodosin 8 mg Tab
Patient Care
Inj Zolendronic Acid 4 mg
Patient Care
| Item # | Title | Description | Quantity | Unit | Consignee | Delivery (Days) | Price Trends |
|---|---|---|---|---|---|---|---|
| 1 | Anastrazole 1 mg Tab | Patient Care | 90 | no | mhcannanore@buyer | 30 | |
| 2 | Tab Folic Acid 5 mg | Patient Care | 90 | no | mhcannanore@buyer | 30 | |
| 3 | Deflazacort 6 mg Tab | Patient Care | 90 | no | mhcannanore@buyer | 30 | |
| 4 | Tab Iguratimod 25 mg | Patient Care | 90 | no | mhcannanore@buyer | 30 | |
| 5 | Ezetimibe 10 mg Tab | Patient Care | 90 | no | mhcannanore@buyer | 30 | |
| 6 | Rosuvastatin 40 mg Tab | Patient Care | 90 | no | mhcannanore@buyer | 30 | |
| 7 | Methotrexate 10 mg Tab | Patient Care | 10 | no | mhcannanore@buyer | 30 | |
| 8 | Inj Degludec or Insulin Aspart of Recombinant DNA Origin of 70 percent Insulin Degludec and 30 percent Insulin Aspart 100 IU or Ml of 3 ml | Patient Care | 12 | pfp or pfs | mhcannanore@buyer | 30 | |
| 9 | Inj Insulin Aspart 100 IU or ml Inj of Monocomponent r DNA Originof 300 IU or 3ml Catridges of Novorapid Penfill | Patient Care | 10 | catridge | mhcannanore@buyer | 30 | |
| 10 | Inj Insulin Aspart 100 IU or Ml Monocomponent DNA Origin of 300 IU or 3ML Pen | Patient Care | 15 | pen | mhcannanore@buyer | 30 | |
| 11 | Recombinant Somatropin for Injection 36 IU of 12 mg or ml | Patient Care | 5 | pfs | mhcannanore@buyer | 30 | |
| 12 | Tab Mesalamine 1 point 2 gm | Patient Care | 180 | no | mhcannanore@buyer | 30 | |
| 13 | Mesalamine Suppository 500 mg | Patient Care | 90 | no | mhcannanore@buyer | 30 | |
| 14 | Tab Glimepride 2 mg | Patient Care | 180 | no | mhcannanore@buyer | 30 | |
| 15 | Tab Dapagliflozin 10 mg | Patient Care | 90 | no | mhcannanore@buyer | 30 | |
| 16 | Tab Vildagliptin 50 mg | Patient Care | 180 | no | mhcannanore@buyer | 30 | |
| 17 | Cilnidipine 10 mg Tab | Patient Care | 90 | no | mhcannanore@buyer | 30 | |
| 18 | Telmisartan 40 mg Tab | Patient Care | 90 | no | mhcannanore@buyer | 30 | |
| 19 | Silodosin 8 mg Tab | Patient Care | 90 | no | mhcannanore@buyer | 30 | |
| 20 | Inj Zolendronic Acid 4 mg | Patient Care | 3 | vial | mhcannanore@buyer | 30 |
Required Documents
Experience Criteria
Past Performance
Bidder Turnover
Certificate (Requested in ATC)
OEM Authorization Certificate
OEM Annual Turnover
Additional Doc 1 (Requested in ATC) *In case any bidder is seeking exemption from Experience / Turnover Criteria
the supporting documents to prove his eligibility for exemption must be uploaded for evaluation by the buyer
Technical Results
| S.No | Seller | Item | Date | Status |
|---|---|---|---|---|
| 1 | AAP PHARMA Under PMA | - | 18-02-2025 13:50:14 | |
| 2 | FASTCARE PHARMA Under PMA | - | 18-02-2025 11:48:10 | |
| 3 | J&J PRODUCTS Under PMA | - | 20-02-2025 21:08:29 | |
| 4 | M/S SRD HEALTH CARE Under PMA | - | 24-02-2025 18:43:47 | |
| 5 | NAINETH ENTERPRISES Under PMA | - | 24-02-2025 13:18:01 | |
| 6 | South End Trade Links Under PMA | - | 20-02-2025 16:07:11 | |
| 7 | SUNIL PHARMACY Under PMA | - | 24-02-2025 17:33:51 | |
| 8 | TOTOMED INTERNATIONAL PRIVATE LIMITED Under PMA | - | 04-02-2025 11:47:54 | |
| 9 | Vitality21 Biosciences LLP Under PMA | - | 17-02-2025 13:52:12 |
Financial Results
| Rank | Seller | Price | Item |
|---|---|---|---|
| L1 | Vitality21 Biosciences LLP(MSE)( MSE Social Category:General ) Under PMA | Item Categories : Anastrazole 1 mg Tab,Tab Folic Acid 5 mg,Deflazacort 6 mg Tab,Tab Iguratimod 25 mg,Ezetimibe 10 mg | |
| L2 | SUNIL PHARMACY (MSE,MII)( MSE Social Category:General ) Under PMA | Item Categories : Anastrazole 1 mg Tab,Tab Folic Acid 5 mg,Deflazacort 6 mg Tab,Tab Iguratimod 25 mg,Ezetimibe 10 mg | |
| L3 | South End Trade Links (MII) Under PMA | Item Categories : Anastrazole 1 mg Tab,Tab Folic Acid 5 mg,Deflazacort 6 mg Tab,Tab Iguratimod 25 mg,Ezetimibe 10 mg | |
| L4 | NAINETH ENTERPRISES (MSE,MII)( MSE Social Category:OBC ) Under PMA | Item Categories : Anastrazole 1 mg Tab,Tab Folic Acid 5 mg,Deflazacort 6 mg Tab,Tab Iguratimod 25 mg,Ezetimibe 10 mg | |
| L5 | FASTCARE PHARMA (MSE,MII)( MSE Social Category:OBC ) Under PMA | Item Categories : Anastrazole 1 mg Tab,Tab Folic Acid 5 mg,Deflazacort 6 mg Tab,Tab Iguratimod 25 mg,Ezetimibe 10 mg | |
| L6 | M/S SRD HEALTH CARE (MSE,MII)( MSE Social Category:General ) Under PMA | Item Categories : Anastrazole 1 mg Tab,Tab Folic Acid 5 mg,Deflazacort 6 mg Tab,Tab Iguratimod 25 mg,Ezetimibe 10 mg | |
| L7 | AAP PHARMA (MSE,MII)( MSE Social Category:General ) Under PMA | Item Categories : Anastrazole 1 mg Tab,Tab Folic Acid 5 mg,Deflazacort 6 mg Tab,Tab Iguratimod 25 mg,Ezetimibe 10 mg | |
| L8 | J&J PRODUCTS (MSE,MII)( MSE Social Category:OBC ) Under PMA | Item Categories : Anastrazole 1 mg Tab,Tab Folic Acid 5 mg,Deflazacort 6 mg Tab,Tab Iguratimod 25 mg,Ezetimibe 10 mg |
Frequently Asked Questions
Key insights about KERALA tender market
What are the eligibility requirements for participating in the Procurement of Medicines tender?
The eligibility requirements include being a registered entity, possessing necessary certifications, and demonstrating relevant experience in the pharmaceutical sector. Bidders must provide supporting documents such as OEM Authorization Certificates and evidence of compliance with experience criteria, which are critical for the evaluation process.
What technical specifications must the medicines meet for this procurement?
All medicines must comply with the quality standards set by healthcare authorities, including full documentation of efficacy and safety through certificates of analysis. Bidders must ensure their products meet all technical specifications stated in the tender to ensure successful procurement.
What are the financial requirements for the GEM/2025/B/5861873 tender?
The financial requirements mandate bidders to demonstrate adequate annual turnover. Additionally, financial documents reflecting the capacity to fulfill large orders must be submitted. Compliance with payment terms stipulated in the tender is also essential for successful bid consideration.
How should bids be submitted for the Procurement of Medicines tender?
Bids can be submitted electronically. The required documents must be uploaded in an accepted format as outlined in the tender documentation. It's crucial to ensure that all necessary documents are completed and submitted to avoid disqualification from the evaluation process.
What provisions are there for Micro, Small, and Medium Enterprises (MSEs) pertaining to this tender?
The tender includes special provisions to encourage participation from MSEs and startups. Detailed information regarding these benefits can be found in the specific sections of the tender document that outline the eligibility criteria and support for such enterprises.
Explore More Opportunities
Unlock Tender Documents
Sign up now to access all documents
Documents 5
GeM-Bidding-7423380.pdf
Main Document
BOQ Document
BOQ
BOQ Document
BOQ
Other Documents
OTHER
GEM General Terms and Conditions Document
GEM_GENERAL_TERMS_AND_CONDITIONS